The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Evaluation of Dose-Related Effects of Aspirin on Platelet Function: Results From the Aspirin-Induced Platelet Effect (ASPECT) Study
Open accessAbstract
Background— The antiplatelet effect of aspirin is attributed to platelet cyclooxygenase-1 inhibition. Controversy exists on the prevalence of platelet resistance to aspirin in patients with coronary artery disease and effects of aspirin dose on inhibition. Our primary aim was to determine the degree of platelet aspirin responsiveness in patients, as measured by commonly used methods, and to study the relation of aspirin dose to platelet inhibition. Methods and Results— We prospectively studied the effect of aspirin dosing on platelet function in 125 stable outpatients with coronary artery disease randomized in a double-blind, double-crossover investigation (81, 162, and 325 mg/d for 4 weeks each over a 12-week period). At all doses of aspirin, platelet function was low as indicated by arachidonic acid (AA)-induced light transmittance aggregation, thrombelastography, and VerifyNow. At any 1 dose, resistance to aspirin was 0% to 6% in the overall group when AA was used as the agonist, whereas it was 1% to 27% by other methods [collagen and ADP-induced light transmittance aggregation, platelet function analyzer (PFA-100)]. Platelet response to aspirin as measured by collagen-induced light transmittance aggregation, ADP-induced light transmittance aggregation, PFA-100 (81 mg versus 162 mg, P ≤0.05), and urinary 11-dehydrothromboxane B 2 was dose-related (81 mg versus 325 mg, P =0.003). No carryover effects were observed. Conclusions— The assessment of aspirin resistance is highly assay-dependent; aspirin is an effective blocker of AA-induced platelet function at all doses, whereas higher estimates of resistance were observed with methods that do not use AA as the stimulus. The observation of dose-dependent effects despite nearly complete inhibition of AA-induced aggregation suggests that aspirin may exert antiplatelet properties through non–cyclooxygenase-1 pathways and deserves further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Eikelboom, J. W., Hirsh, J., Weitz, J. I., Johnston, M., Yi, Q., & Yusuf, S. (2002) · Circulation · doi:10.1161/01.cir.0000013777.21160.07 · Cited by 1,053
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
Gum, P. A., Kottke-Marchant, K., Poggio, E. D., Gurm, H., Welsh, P. A., Brooks, L., Sapp, S. K., & Topol, E. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01631-9 · Cited by 820
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Platelet Reactivity in Patients and Recurrent Events Post-Stenting
Gurbel, P. A., Bliden, K. P., Guyer, K., Cho, P. W., Zaman, K. A., Kreutz, R. P., Bassi, A. K., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.041 · Cited by 644
Self-citationDesign and Analysis of Cross-Over Trials
Jones, B., & Kenward, M. G. (2003) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420036091 · Cited by 484
Chen, W.-H., Lee, P.-Y., Ng, W., Tse, H.-F., & Lau, C.-P. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.034 · Cited by 474
Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
Cattaneo, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145980.39477.a9 · Cited by 411
Development of aspirin resistance in persons with previous ischemic stroke.
Helgason, C. M., Bolin, K. M., Hoff, J. A., Winkler, S. R., Mangat, A., Tortorice, K. L., & Brace, L. D. (1994) · Stroke · doi:10.1161/01.str.25.12.2331 · Cited by 408
Gurbel, P. A., Bliden, K. P., Zaman, K. A., Yoho, J. A., Hayes, K. M., & Tantry, U. S. (2005) · Circulation · doi:10.1161/01.cir.0000157138.02645.11 · Cited by 353
Self-citationAspirin resistance: position paper of the Working Group on Aspirin Resistance
MICHELSON, A. D., CATTANEO, M., EIKELBOOM, J. W., GURBEL, P., KOTTKE‐MARCHANT, K., KUNICKI, T. J., PULCINELLI, F. M., CERLETTI, C., & RAO, A. K. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01351.x · Cited by 325
Self-citationTantry, U. S., Bliden, K. P., & Gurbel, P. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.090 · Cited by 324
Self-citationAspirin resistance: definition, mechanisms and clinical read-outs
Patrono, C. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00284.x · Cited by 299
Zimmermann, N., Wenk, A., Kim, U., Kienzle, P., Weber, A.-A., Gams, E., Schrör, K., & Hohlfeld, T. (2003) · Circulation · doi:10.1161/01.cir.0000081770.51929.5a · Cited by 287
Schwartz, K. A., Schwartz, D. E., Ghosheh, K., Reeves, M. J., Barber, K., & DeFranco, A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.12.038 · Cited by 210
Paired analysis of urinary thromboxane B2 metabolites in humans
Catella, F., & Fitzgerald, G. A. (1987) · Thrombosis Research · doi:10.1016/0049-3848(87)90103-4 · Cited by 199
Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
Lee, P.-Y., Chen, W.-H., Ng, W., Cheng, X., Kwok, J. Y.-Y., Tse, H.-F., & Lau, C.-P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.041 · Cited by 185
Harrison, P., Segal, H., Blasbery, K., Furtado, C., Silver, L., & Rothwell, P. M. (2005) · Stroke · doi:10.1161/01.str.0000162719.11058.bd · Cited by 164
Mikkelsson, J., Reséndiz, J. C., Viiri, L. E., Backman, J. T., Kankuri, E. M., Karhunen, P. J., Lassila, R., & Lepäntalo, A. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-07-0516 · Cited by 113
Resistance to antiplatelet drugs: current status and future research
Tantry, U. S., Bliden, K. P., & Gurbel, P. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.2027 · Cited by 73
Self-citationAspirin insensitive eicosanoid biosynthesis in cardiovascular disease
Patrignani, P. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00382-7 · Cited by 63
Antiplatelet Therapy: Current Strategies and Future Trends
Tantry, U. S., Etherington, A., Bliden, K. P., & Gurbel, P. A. (2006) · Future Cardiology · doi:10.2217/14796678.2.3.343 · Cited by 40
Self-citation
Cited by
Gurbel, P. A., Bliden, K. P., Butler, K., Tantry, U. S., Gesheff, T., Wei, C., Teng, R., Antonino, M. J., Patil, S. B., Karunakaran, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.912550 · Cited by 1,159
Self-citationWeitz, J. I., Eikelboom, J. W., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2294 · Cited by 527
Platelet Function Monitoring in Patients With Coronary Artery Disease
Gurbel, P. A., Becker, R. C., Mann, K. G., Steinhubl, S. R., & Michelson, A. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.051 · Cited by 478
Self-citationEikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2012) · Chest · doi:10.1378/chest.11-2293 · Cited by 379
Gilard, M., Barragan, P., Noryani, A. A. L., Noor, H. A., Majwal, T., Hovasse, T., Castellant, P., Schneeberger, M., Maillard, L., Bressolette, E., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.008 · Cited by 360
Metadata
- Authors
- Gurbel, P. A., Bliden, K. P., DiChiara, J., Newcomer, J., Weng, W., Neerchal, N. K., Gesheff, T., Chaganti, S. K., Etherington, A., & Tantry, U. S.
- Venue
- Circulation
- Published
- 2007-06-26
- Volume
- 115
- Issue
- 25
- Pages
- 3156-3164
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2072518791
- Cited by
- 417
- References
- 26
- FWCI
- 29.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.